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Abstract
Background and Aims
When a person with dementia (PWD) has lost the ability to make treatment decisions, clini-
cians often rely on family carers to know and articulate these preferences with assumed
accuracy. This study used the Life Support Preferences Questionnaire (LSPQ) to explore
whether family carers’ choices show agreement with the end of life care preferences of the
person with dementia for whom they care and what factors influence this.
Methods
A cross-sectional study interviewing 60 dyads (a person with early dementia and preserved
capacity and their family carer) each completing a modified LSPQ. We assessed how
closely carers’ choices resembled the PWD’s preferences for treatment in three proposed
health states: the here and now; severe stroke with coma; terminal cancer. Agreement
between the PWD and their family carer responses was assessed using Kappa and Preva-
lence-Adjusted Bias-Adjusted Kappa (PABAK) statistics. We examined whether carer bur-
den and distress, and relationship quality, influenced agreement.
Results
In interviews PWDwere able to indicate their treatment preferences across all three scenar-
ios. In the here-and-nowmost wanted antibiotics (98%), fewer cardio-pulmonary resuscita-
tion (CPR) (50%) and tube feeding (47%). In severe stroke and coma antibiotics remained
the more preferred treatment (88%), followed by CPR (57%) and tube feeding (30%). In
advanced cancer PWD expressed lower preferences for all treatments (antibiotics 68%;
CPR 50%; tube feeding 37%). Carers’ choices were similar to the PWDs’ preferences in the
here-and-now (71% (k = 0.03; PABAK = 0.4) with less agreement for future hypothetical
health states. In severe stroke and coma carers tended wrongly to suggest that the PWD pre-
ferred more intervention (antibiotic, 67%; k = -0.022; PABAK = -0.60; CPR, 73%; k = 0.20;
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PABAK = -0.20, tube feeding, 66%; k = 0.25; PABAK = -0.12). In advanced cancer the
agreement between PWD and carers was low (antibiotics; k = -0.03; PABAK = -0.52; CPR,
k = -0.07; PABAK = -0.45; tube feeding; k = 0.20; PABAK = -0.22). However, both PWD and
carers showed marked uncertainty about their preferences for end of life treatment choices.
Relationship quality, carer distress and burden had no influence on agreement.
Conclusions
This study is the first to have used the LSPQ with PWD in the UK to consider treatment
options in hypothetical illness scenarios. Key finding are that family carers had a low to mod-
erate agreement with PWD on preferences for end of life treatment. This underscores how
planning for care at the end of life is beset with uncertainty, even when the carer and PWD
perceive the care-giving/receiving relationship is good. Families affected by dementia may
benefit from early and ongoing practical and emotional support to prepare for potential
changes and aid decision making in the context of the realities of care towards the end of
life.
Introduction
An ageing population and dementia
There are an estimated 835,000 people currently living with dementia in the UK which will rise
to over two million by 2050 [1]. Dementia is a degenerative disease and thus a life-limiting con-
dition. Failure to recognise dementia as a terminal illness and that it is often accompanied by
multi morbidity has, until recently, led to neglect in addressing end of life challenges for people
with dementia (PWD) and their carers [2].
Planning end of life care in dementia
Interest in palliative and end of life care for people with dementia is increasing [3,4]. The UK,
the End of Life Care Strategy [5], English National Dementia Strategy [6] and Prime Ministers
Challenge [7] have all called for improvement in care towards the end of life in dementia by
promoting ‘advance care planning’. It has been suggested that all people should be encouraged
to identify their needs, priorities and preferences for end of life care [5]. This may be challeng-
ing for people with cognitive impairment and in those with reduced capacity to express their
preferences.
Dementia and decision making
Autonomy in decision making depends upon consciousness of our past and future thoughts
and actions in the same way as we are conscious of our present thoughts and actions [8]. How-
ever, as dementia progresses, in particular the ability to consider future thoughts and actions
become compromised and this affects the capacity to make decisions [9]. Capacity, in the con-
text of decision making, refers to the ability to consider and weigh up information relevant to a
situation, retain it and communicate that decision [10]. In dementia decisions vary in complex-
ity and importance, ranging for example from decisions to be made about a health crisis to
those about day to day needs. Older people often trust loved ones to make healthcare decisions
on their behalf [11] and want those decisions to be in keeping with their own wishes and
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Quality of Carer Patient Relationship; ZBI, Zarit
Burden Inventory.
preferences [12]. Family carers are assumed to know what these wishes and preferences would
have been had the person with dementia not lost capacity [13] and professionals often rely on
family members to predict and articulate these preferences with assumed accuracy [14].
Accuracy in predicting the wishes and preferences of the person with
dementia
Making decisions about end of life care and treatment on behalf of a family member may be
difficult, for example considering whether to withhold treatment, choosing between treatment
options and taking note of the context of the decision, for example, in a crisis as compared to
states of chronic ill-health [15,16]. Family carers’ patterns of decision-making differ according
to their previous experiences of end of life care [17], education, perceived carer burden [18],
psychological distress and cultural background [19]. Not surprisingly, carers often find making
health-related decisions for the person they care for stressful [20]. Decisions concerning end of
life care are amongst the most difficult [21]. Families who are in conflict or with poor inter-
relational dynamics may be more likely to opt for active treatment [22,23] rather than palliative
care [23]. However, even in the absence of such conflict, when a family is in doubt or uncertain
as to what to decide, they may err on the side of caution and elect for life-sustaining treatment
for the person with dementia.
Aims and objectives
In this study we aimed to increase understanding of the treatment and care preferences of
PWD and particularly whether family carers’ choices are in agreement.
Our specific objectives were: a) to use a modified version of the Life Support Preferences
Questionnaire (LSPQ) [24] to explore the choices PWDmake for end of life care, b) to examine
how accurately family carers of a PWD agree with their wishes and preferences for end of life
care, c) to examine factors that might influence this agreement and levels of uncertainty in
choices for treatment in both the PWD and the family carer.
Methods
Design and Study population
A cross sectional interview study of dyads of PWD and their family carer or close friend.
Recruitment
Dyads were identified by psychiatrists and registered nurses in memory clinics, community
mental health teams or coordinators of dementia research registers in four different sites in
England: 1) Barnet Enfield & Haringey Mental Health Trust, 2) Cambridge and Peterborough
Foundation Trust, 3) West London Mental Health Trust and 4) Leicestershire Partnership
Trust.
Inclusion criteria for PWD were a clinical diagnosis of any type of dementia as categorised
in ICD-10 [25], a Mini Mental State Examination score [26] 20 and the mental capacity to
consent to and participate in the interview. Carers were included if identified as next of kin or
key decision maker for the PWD. Dyads were excluded if either the PWD or carer did not con-
sent to take part and if either was unable to communicate sufficiently in English, as no funding
was available for use of interpreters.
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Procedure
Potential participants were identified by clinicians in each of the four sites. They assessed the
capacity of both the PWD and carer who expressed interest in involvement. The researcher
then made contact with the nominated contact person of each dyad, usually the carer, to
arrange the interview. Capacity of the PWD was reassessed by the researcher (KHD) prior to
commencement of the interview. Interviews were held in the participants’ choice of location.
The aims of the study were explained to the both the PWD and their carer. Written consent
from both the PWD and carer was then obtained. Each participant was interviewed separately;
the PWD first and carer second. Interviews lasted approximately one hour and were carried
out by KHD between April 2012 and February 2014. If either the PWD or their carer became
distressed at any time during the research process, they were offered the support of Admiral
Nursing DIRECT and if necessary the interview was terminated.
Socio-demographic data
We recorded the socio-demographic characteristics of the PWD and carer (age, gender, ethnic-
ity, education, employment, and living situation), as well as the relationship between the carer/
friend and PWD.
Measures: people with dementia
We used two instruments:
1. Quality of Carer Patient Relationship (QCPR) [27]. This is a 14-item scale that examines
agreement on quality of the relationship between a caregiver and a care recipient. Responses
are given on a 5-point Likert scale, ranging from ‘totally disagree’ to ‘totally agree’, giving a
range of scores from 14 to 70, with higher values representing better relationships.
2. A modified version of the Life Support Preferences Questionnaire (LSPQ) [24]. The LSPQ
questionnaire is an American tool using nine health state scenarios to support the develop-
ment of advance directives. As our aim was to explore how well carers’ agreed with the treat-
ment preferences of the PWD, we modified the LSPQ to three scenarios for participants to
consider. One scenario featured the prospect of developing dementia, and as our target pop-
ulation already had a diagnosis of dementia, we described our first scenario as, ‘as you are
today, with mild memory problems’. The two other scenarios we selected were stroke with
coma and advanced cancer as most people understand or have had experience of these con-
ditions amongst family and friends (see Box 1).
People with dementia were asked to consider themselves in each scenario and indicate their
preference for receiving three discrete life-sustaining medical treatments in each of the three
scenarios using a five point Likert Scale (‘definitely would want’, ‘probably would want’,
‘unsure’, ‘probably would not want’ and ‘definitely would not want’). The treatments were anti-
biotics, cardio-pulmonary resuscitation and tube feeding. Each treatment was explained to par-
ticipants as often as necessary and a ‘prompt card’ (see Box 2) was used when needed.
Measures: Carers
We used four instruments:
1. Zarit Burden Interview (ZBI) [28]. Comprising 22 items, the ZBI assesses the current burden
experienced by caregivers. Items are scored on a rating scale ranging from 0 (never) to 4
(almost always); total scores range between 0 and 88, higher scores indicating greater burden.
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2. The Kessler Psychological Distress Scale (K10) [29] is a 10-item measure of psychological
distress based on expressed levels of anxiety and depressive symptoms. Items are scored on
a rating scale ranging from 1 (none of the time) to 5 (all of the time) with higher scores indi-
cating greater psychological distress.
Box 1. Life Support Preference Questionnaire Health states
SCENARIO 1
Imagine you are in your current health, in other words, the way you are feeling now.
SCENARIO 2
Imagine you have suffered a severe stroke and have been in a coma for six weeks.
In the opinion of your doctor, you have no chance of regaining awareness or the abil-
ity to think, reason, and remember.
Your current physical condition is stable, but will slowly decline over time. You rely
on others for help with feeding, bathing, dressing, and toileting. You may live in this con-
dition for several years.
SCENARIO 3
Imagine you have advanced cancer and it has spread to other areas. You are tired and
weak, requiring some help with household chores. Imagine you have a pain that requires
the constant use of medication. In the opinion of your doctor, you have no chance of
recovery. Your doctor estimates that you have about six months to live.
Box 2. Life Support Preference Questionnaire Treatment choices
1. Antibiotics
Doctors use these medicines to treat serious infections (e.g., pneumonia). Without anti-
biotics, serious infections can cause life threatening complications or death.
2. Cardiopulmonary Resuscitation (CPR)
Doctors use cardiopulmonary resuscitation, or CPR, when a person's heart stops beating
or a person stops breathing. Doctors press on the chest to help pump blood, and use arti-
ficial breathing. Artificial breathing means the doctor puts a tube in the windpipe. Then,
a machine breathes for the patient through the tube. Patients usually get medicines by
vein. Patients often need an electrical shock to help restart the heartbeat. Without CPR,
the heart will not start beating again, and the patient will die.
3. Artificial Feeding and Fluids
Doctors use artificial feeding and fluids when people are unable to take enough food and
water to stay alive. The food goes through a feeding tube. Usually, the feeding tube goes
through the skin into the stomach. Without this treatment, patients die within 710 days.
Advance Care Planning and Treatment Preferences
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3. Quality of Carer Patient Relationship (QCPR) [27]. (The PWD had indicated their
responses earlier in the interview).
4. The modified LSPQ [24] where the carer was asked to predict those preferences previously
made by the person with dementia.
Statistical analysis
Descriptive statistics were used to summarise the demographic features of the cohort. We
report the frequencies and percentages of the ZBI and K10. The scores were also categorised to
indicate levels of carer burden e.g. ‘severe carer burden’ (score = 61–88) (ZBI) [30], and ‘mod-
erate mental disorder’ (score = 25–29) (K10). The QCPR scores were dichotomised into ‘good’
and ‘poor’ relationships using the median carer scores, a method developed by Spruttye et al
[27]. The median score in the present study cohort was 60, so a dyad was counted as being in
the ‘good’ relationship category if either the PWD or the carer achieved a score of 60 or above.
For the LSPQ, we created indices, dichotomizing the scale by collapsing ‘definitely want’,
‘probably want’, and ‘unsure’ responses into a want treatment category, and ‘definitely don't
want’ and ‘probably don't want’ into a don't want treatment category [31,32]. We categorized
‘unsure’ responses with ‘want treatment’ responses because the clinical default is often to
provide treatment unless specifically refused personally or in an advance decision to refuse
treatment. Thus, we assigned a value of zero for ‘do not want treatment’ and one for ‘want
treatment’. However, to ensure any level of uncertainty was captured, ‘unsure’ responses were
also examined and analysed separately.
The three LSPQ scenarios were expressed in 2x2 tables and described using percentage
agreement and the kappa coefficient. Due to the unbalanced distribution of the cell counts in
the 2x2 tables the Prevalence Adjusted Bias Adjusted Kappa (PABAK) measure was also
applied to all calculations [33]. The level of agreement was described using indices developed
by Fleiss et al. [34].
We used the modified LSPQ data to develop an ‘agreement index’ that reflected levels of
agreement on treatment preferences. Where a carer could accurately estimate the PWD’s treat-
ment preference, whether that was for active treatment or not, they gained a score of one.
Uncertainty only achieved a score of one if that also predicted uncertainty for the treatment
preference of the PWD. Thus, we used a score of 0–9; 0 = no ability to predict through to
9 = full ability to predict treatment preferences. Combining scores from all carers gave an over-
all indication of level of agreement in the sample. Given there was very little missing data for
items in measures such as the K10 and ZBI, missing values were replaced by the mean for
patients with complete data [35].
Finally, we used multiple linear regression to explore the association between carer and
PWD’s characteristics and agreement scores.
Ethical considerations
The study was approved by the NHS Health Research Authority, NRES Committee South East
Coast—Surrey in January 2012 (12/LO/0106).
Results
Description of sample
The cohort comprised 60 dyads of a PWD and a family carer or friend recruited from four
study sites, the majority recruited from site 1 (see Table 1). Overall we approached 79 dyads
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over the four sites, of whom 17 declined to participate (76% response rate). The commonest
reason for refusal (n = 8) was the carer declining on behalf of the dyad due to their own level of
‘stress’. Demographic characteristics of the cohort are presented in Table 2.
Treatment choices and carer agreement in prediction
LSPQ data are presented as the treatment preferences for active or non-active treatment (see
Tables 3 & 4) and the carer’s ability to discern these.
Scenario One (‘as you are today’). Most PWD (98%) expressed a preference to receive
antibiotics. However, the preference for active treatment was lower for CPR (88%) and tube
feeding (65%). Carer and PWD agreement was highest for antibiotic treatment in scenario one
The level of agreement for tube feeding was no better than chance, 20% (k = -0.02; PABAK =
-0.60) (see Table 5).
Scenario Two (severe stroke with coma). about half of the PWD showed a preference for
no active treatment (antibiotics, 50%; CPR, 57%; tube feeding, 50%) (See Table 3). Carers
agreed less in this scenario tending to overestimate the PWD’s desire for no treatment (antibi-
otic, 67%; CPR, 73%, tube feeding, 66%) (See Table 4). Carers’ ability to estimate the treatment
choices of the PWD was lower than in scenario one. In the choice of antibiotic treatment, the
strength of agreement was ‘poor’ at 22% (k = -0.022; PABAK = -0.60). There was a 42% level of
agreement in the choice of CPR (k = 0.20; PABAK = -0.20). Carers were able to predict the
treatment choice of tube feeding with a 44% agreement (k = 0.25; PABAK = -0.12) (See
Table 5).
Scenario Three (Advanced cancer). People with dementia were more in favour of anti-
biotic treatment (47%) than other treatment options (CPR, 30%; tube feeding, 37%) (See
Table 3). Carers had similar views to PWD overall (antibiotics, 55%, CPR, 31%; tube feeding,
37%) (See Table 4). However, when it came to concordance within dyads, the level of agree-
ment was low; antibiotic treatment was only 24% which was rated poor (k = -0.03; PABAK =
-0.52). For CPR, agreement was also low at 27% but with only ‘poor’ reliability indicated
(k = -0.07; PABAK = -0.45). Concordance between the PWD and carer for tube feeding was
39%, however this was only ‘low’ strength (k = 0.20; PABAK = -0.22) (see Table 5).
Antibiotic treatment achieved the highest level of all treatment options in all scenarios at
71% (k = 0.03; PABAK = 0.4).
Uncertainty
When either the PWD or the carer expressed uncertainty by choosing the ‘unsure’ response on
the modified LSPQ, this was potentially lost in the way the modified LSPQ scores were later
Table 1. Recruitment to study.
Site Dyads who were approached Dyads who refused or were excluded Dyads who were interviewed
1. BEH 52 10 (19%) 42 (81%)
2. CPT 9 1 (11% 8 (89%)
3. WLMHT 12 4 (33%) 8 (67%)
4. LPT 6 4 (67%) 2 (33%)
Total 79 19 (24%) 60
Note: Dyad = person with dementia and their family carer/friend; BEH = Barnet Enﬁeld & Haringey MH NHS Trust; CPT = Cambridge and Peterborough
Foundation Trust; WLMHT =West London Mental Health Trust; LPT = Leicestershire Partnership MH Trust.
doi:10.1371/journal.pone.0159056.t001
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dichotomised and analysed. In scenario one, PWD were confident in making their preferred
treatment choices, and carers agreed with this. However, the selection of the ‘unsure’ response
increased for treatments of CPR and tube feeding and within scenarios two and three (see
Tables 6 & 7).
Table 2. Characteristics of dyads (n = 60).
PWD (n = 60) Carers (n = 60)
Age (mean (SD) [range]) 79.2 (6.8) [58–93] 66.6 (12.8) [39–93]
Gender (% male) 26 (43%) 19 (32%)
MMSE (mean (SD) [range]) 25.4 (2.4) [20–29]
Diagnosis
F00.1 (Alzheimer’s late onset) 40 (67%)
F00.2 (atypical or mixed type Alzheimer’s) 12 (20%)
other 8 (13%)
Ethnicity
White British 38 (63%) 42 (70%)
White other* 16 (27%) 12 (20%)
Other** 6 (10%) 6 (10%)
Previous education
Left school 14 years 14 (23%) 5 (8%)
Left school 15 years 46 (77%) 55 (92%)
Living situation of PWD
Alone 14 (23%)
Spouse/partner 37 (62%)
Other 9 (15%)
Relationship to PWD
Spouse 35 (58%)
Adult child 18 (30%)
Other 7 (12%)
Employment—SOC 2010
1. Higher managerial, administrative and professional qualiﬁcations 28 (47%) 31 (52%)
2. Intermediate occupations 15 (25%) 18 (30%)
3. Routine and manual occupations 16 (27%) 9 (15%)
Never worked or long-term unemployed 0 1
Missing 1 1
Note: PWD = Person with dementia. MMSE = Mini Mental State Examination. ICD 10 = International Disease
Classiﬁcation. SOC = National Statistics Standard Occupational Classiﬁcation.
*White other includes Irish, Jewish, Greek Cypriot, Turkish Cypriot, Polish and Russian.
** African Caribbean, Indian and Bangladeshi.
doi:10.1371/journal.pone.0159056.t002
Table 3. PWD preference for active treatment (N/%).
Treatment Scenario 1: As you are today Scenario 2: Severe stroke with coma Scenario 3: Advanced cancer
Antibiotics 59 (98%) 28 (47%) 28 (47%)
CPR 53 (88%) 20 (33%) 18 (30%)
Tube feeding 39 (65%) 23 (38%) 22 (37%)
Note: No missing data
doi:10.1371/journal.pone.0159056.t003
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Carer burden, distress and quality of relationship
On the ZBI, almost half of carers (40%) perceived ‘mild to moderate’ levels of carer burden’,
32% ‘little or no burden’ and 27% ‘moderate to severe burden’. Analysis of the K10 indicated
the majority of carers fell within the range defined as ‘well’ (score<20; 66.7%). Eight (13.3%)
were defined as having a ‘mild mental disorder’, 10% as having a ‘moderate mental disorder’,
and 10% a ‘severe mental disorder’ (score 30). Analysis of QCPR data showed no statistically
Table 4. Carer predictions for PWD choice for active treatment (N/%).
Treatment Scenario 1: As you are today Scenario 2: Severe stroke with coma Scenario 3: Advanced cancer
Antibiotics 56 (95%) 17 (29%) 33 (56%)
CPR 49 (83%) 10 (17%) 19 (32%)
Tube feeding 30 (51%) 16 (27%) 22 (37%)
doi:10.1371/journal.pone.0159056.t004
Table 5. LSPQ—carer’s ability to accurately estimate the treatment preferences of PWD presented as agreement.
LSPQ Scenario % Agreement % Expected agreement Kappa (k) PABAK
Scenario 1 ‘As you are today’
Antibiotics 71.2 59.4 0.34 0.42
CPR 62.7 45.2 0.30 0.30
Tube feeding 20.3 22.0 -0.018 -0.60
Scenario 2 ‘Severe stroke with coma’
Antibiotics 22.0 24.0 -0.022 -0.60
CPR 42.4 30.0 0.21 -0.20
Tube feeding 44.1 26.0 0.25 -0.12
Scenario 3 ‘Advanced cancer’
Antibiotics 24.0 21.4 0.03 -0.52
CPR 27.1 32.0 -0.07 -0.45
Tube feeding 39.0 23.4 0.20 -0.22
Note: LSPQ = Life Support Preferences Questionnaire; PWD = Person with dementia; PABAK = Prevalence And Bias Adjusted Kappa; CPR = cardio
pulmonary resuscitation.
doi:10.1371/journal.pone.0159056.t005
Table 6. PWD—‘Unsure’ of preference for treatment choice.
Treatment Scenario 1: As you are today Scenario 2: Severe stroke with coma Scenario 3: Advanced cancer Total
Antibiotics 0 2 (3%) 7 (12%) 9 (15%)
CPR 1 (1%) 6 (10%) 6 (10%) 13 (22%)
Tube feeding 8 (13%) 7 (12%) 7 (12%) 22 (37%)
Total 9 (15%) 15 (25%) 23 (35%)
doi:10.1371/journal.pone.0159056.t006
Table 7. Carer–‘Unsure’ of PWD’s preference for treatment choice.
Treatment Scenario 1: As you are today Scenario 2: Severe stroke with coma Scenario 3: Advanced cancer Total
Antibiotics 0 2 (3%) 6 (10%) 8 (14%)
CPR 2 (3%) 5 (8%) 4 (7%) 11 (19%)
Tube feeding 10 (16%) 3 (5%) 3 (5%) 16 (27%)
Total 12 (20%) 10 (17%) 13 (22%)
doi:10.1371/journal.pone.0159056.t007
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significant association between the quality of the relationship as perceived by the PWD and
that perceived by carers (Pearson’s r = -0.048; P = 0.718).
Association between carer measures and life support preferences
No significant association was revealed between the Life Support Preference Questionnaire
and the variables examined (i.e. care burden, distress and quality of care giver/care receiver
relationship).
Discussion
The treatment preferences of PWD varied across the three scenarios as did family carers’ agree-
ment with those preferences, with a significant degree of decisional uncertainty in both. Per-
ception of relationship quality, carer burden and distress had no effect on carers’ accuracy in
estimating the PWD’s treatment preferences.
Treatment preferences of PWD
People with dementia indicated their preference for life saving treatments in the here and now.
The wish to receive life sustaining treatments reduced in the future hypothetical scenarios,
especially for CPR and tube feeding.
The hypothetical scenario method can be used to derive information by asking study partic-
ipants how they would act under certain circumstances [36,37]. Hypothetical scenarios are
commonly used in studying sensitive healthcare issues that are difficult to research directly, for
example, asking opinions at the bedside of a dying patient [38]. Whilst all the PWD in our
study met the essential criteria regarded as necessary to be able to undertake ACP [39,40] and
had the capacity to participate, the complex judgments required to place themselves in hypo-
thetical health states may have presented too great a challenge. Our nominal group study [41]
showed that PWD find it difficult to contemplate their future selves in hypothetical scenarios,
for example, what circumstances might present in the future that may prevent them continuing
to live in their own home. This suggests that they would have difficulties making care planning
decisions for the future and thus they (as well as their clinicians) may rely on their families and
friends. Unfortunately, our results indicate that such reliance may be misplaced.
Treatment preferences in relation to different health states
There has been little exploration of the future treatment preferences of PWD. This presumably
reflects either an assumption that they lack capacity to express a consistent view or else a reluc-
tance to raise sensitive topics with PWD. However, we found that PWD could express their
preferences and that there were notable differences across the three health state scenarios. They
were more likely to show a preference for antibiotic treatment across all proposed health states
but much less likely to opt for more ‘invasive’ treatments, such as tube feeding, this especially
so in stroke with coma and this concurs with the findings of Low et al.[42] in interviews with
nursing home residents who did not have dementia
Our findings are consistent with other studies investigating the views of older people
[43,44] where participants (who did not have dementia) wished to forego treatments in the
event of being in a coma. However, Scandrett et al. [45] found little consistency in treatment
preferences across a range of hypothetical health states. However, neither of these studies
involved participants with dementia; indeed, dementia was presented as one of the hypothetical
scenarios.
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We cannot assume that in the event of a diagnosis of dementia that people’s end of life care
treatment and care preferences will change. Indeed, our findings suggest that they maybe do
not change much. Therefore, any discussions about end of life care should start with the PWD.
Schellinger et al. [46] advocated the use of disease-specific advance care planning, conducted
by clinicians who are knowledgeable and skilled in communication relating to the life limiting
condition with which a person is diagnosed. Though they did not test this approach in demen-
tia, Schellinger and colleagues reported improvements in end of life care communication for
people with heart disease, with a correspondingly increased access to hospice care.
Carers’ agreement with the treatment preferences of PWD
Carers’ agreement with the end of life treatment preferences of the PWD varied across the
three scenarios. Most carers agreed with the PWD’s preferences in the here and now, perhaps
because it is a known situation that requires less consideration, concurring with findings of
similar studies [47]. However, as the scenarios increasingly focused on severe future illness
states, carers’ and PWD’s level of agreement became, at best, moderate. The more interven-
tional treatments, such as CPR and tube feeding, showed lower levels of agreement across all
scenarios. This may be due in part to most carers having previous knowledge and experience of
antibiotic treatment whereas CPR and tube feeding may be less familiar to them or indeed be
seen as more emotive and ‘high stakes’ as treatment options. Overall, carers showed a moderate
to low ability to estimate the treatment preferences of the PWD, and lower than that found in
other research [13,41,47].
In general, research on carers’ ability to predict accurately the preferences of a PWD have
produced conflicting findings. Whitlach et al [12] examined the accuracy of family carers’ abil-
ity to estimate the PWD’s treatment preferences and concluded it to be ‘adequate’, but without
specifying what ‘adequate’ actually meant. In contrast, Shalowitz et al [47] found that, in one-
third of cases, next-of-kin and patient-nominated decision makers incorrectly predicted
patients' end of life treatment preferences. In their review, they concluded that even discussing
preferences for treatment or designating a person to make decisions on their behalf failed to
improve the surrogates' predictive accuracy.
Factors that might influence accuracy
Our study revealed no association between carer burden and distress or quality of relationship
that influences the ability to predict accuracy in decision making, which is not consistent with
other studies [12,48]. Carers may find it difficult to reconcile their own emotional needs with
those of the person they care for, struggling to decide what they think the person would have
wanted [49]. Although our study did not incorporate a specific measure for this, we found that
both PWD and carers showed marked uncertainty for treatment choices in future scenarios
and choosing the ‘unsure’ response in the LSPQ scale. This is common in dementia care
around issues such as imprecision in diagnosis, lack of information and communication about
prognosis [50] and lack of knowledge about care and treatment options for the future [51].
Mishel [52] proposed a ‘theory of uncertainty’ whereby, especially in chronic illness-related sit-
uations, the decision maker finds it very stressful and difficult to make a judgment or to predict
what an individual might or might not want due to lack of cues and information [53]. In an
earlier study [41] we found that family carers perceived a future with dementia as bleak, which
may in part be due a lack of support, communication and information on what the future
holds for them as a carer, but this may also influence the decisions they think the PWD would
make for themselves. However, the preferences expressed by the PWD in the earlier stages of
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the disease may not be consistent as they move through the illness and adapt to the diagnosis;
their views on what constitutes a good quality of life may change [54].
Methodology and limitations of the study
This study is the first to have used the LSPQ with PWD in the UK in considering treatment
options in hypothetical illness scenarios. The research was undertaken by one interviewer on a
sample that may not be representative of this population. However, issues such as the inevitable
worsening of dementia, impending loss of decision-making capacity, and the likelihood of
future physical illness are universal for all people affected by this condition and their families
and friends.
Recruitment to the study was challenging, despite being extended across four geographical
areas and two dementia research registers. Requiring consent of both parties of the dyad may
have been restrictive in recruitment with either the PWD or their carer in any potential dyad
refusing to take part. As in other studies, carers tended to ‘gate keep’ researcher access to the
PWD [55,56]. Some clinicians were cautious in recommending some dyads, reasoning that
they had only recently received the diagnosis and it was too soon to seek their interest in a
study on ACP and end of life care. This caution may reflect clinician reluctance to discuss the
nature of the research topic for fear of causing distress; however no potential participants
expressed any distress or concern regarding the topic.
A PWDmay find end of life care issues especially difficult to process. Whilst approaches,
such as the LSPQ, may attempt to mimic actual healthcare scenarios, they are in danger of
being minimalist in their descriptions, lacking specific detail and failing to reflect how complex
and emotionally draining decision making can be. This may lead participants to make choices
that may not reflect the reality of a future health state or indeed reflect their wishes and prefer-
ences in the event, so we cannot assume that participants would make these choices when
faced with such a situation. Nor do we know if the PWD’s wishes are simply overridden by the
carer if those views were different. However, the actual outcome of events for these dyads is not
what we measured here. Rather, of interest was carer agreement and the extent to which differ-
ent scenarios led to different patterns of agreement.
The lack of association between measures of the carer relationship, carer burden and levels
of agreement on health preferences was not entirely expected. However, we must emphasise
that this study was may not have been powered to examine these associations.
Significance of this research
This study contributes novel findings about decision making and how PWD and carers might
make choices about future health care. A key finding of this study was that carer burden and
distress did not seem to influence a carer’s ability to estimate the preferences of his or her
PWD, therefore further exploration is required to understand in more depth the complexities
of proxy decision making for PWD at end of life.
Clinical implications
The work has clinical implications, for example further demonstrating the need to take time to
ensure that the PWD (especially) have the relevant information to make their own choices,
where possible, and that these are clearly communicated and recorded, so that any ACP is read-
ily available when required in the future.
There is often an assumption in practice [13,57] that carers and PWD will speak with one
voice but we found this cannot be assumed. This suggests that there is a need for targeted edu-
cational initiatives and support, on the nature and course of dementia but also on how to plan
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ahead and with that dialogue to be revisited and reviewed at frequent intervals. We will need to
give more consideration to the problem of uncertainty if we are to support families in decision
making as the dementia progresses and also to prepare professionals [58] in providing appro-
priate support.
Conclusion
Whilst robust evidence for the presumed benefits of end of life communication and ACP in
dementia is still lacking, this study furthers our understanding of the challenges that face PWD
and their families in considering end of life care treatment preferences. Advance care planning
may offer a range of benefits to PWD and their families such as initiating conversations that
lead to thinking ahead and articulating wishes and preferences for care in the future. But, there
remain significant barriers that will need to be addressed in order to gain optimum outcomes
of any such intervention. PWD find it difficult to conceive of their future selves and think
about preferences for end of life care and in the absence of a process of continued communica-
tion this makes it difficult for them to identify future treatment choices for any possible hypo-
thetical health scenario they may experience. Moreover, their carers, who may be forced to
make proxy decisions, are often not aware of, or cannot estimate, their preferences.
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